Author: Peter Mansell

Sanofi has set out its procedures for expanding access to information and data from the group’s clinical trials, in line with the joint EFPIA-PhRMA Principles for Responsible Clinical Trial Data Sharing that took effect on 1 January 2014.

Cyprotex, the UK-based provider of ADME (Absorption, Distribution, Metabolism and Elimination) and toxicity services, has broadened the scope of its toxicological assay and screening capabilities by acquiring US contract research organisation CeeTox.

The joint principles on “responsible” sharing of clinical-trial data endorsed last July by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) took effect on 1 January 2014.

The US National Institutes of Health (NIH) has announced three new funding opportunities to encourage creative approaches to broadening diversity in the biomedical-research workforce.

A consortium of pharmaceutical companies, academic researchers and analytical development specialists has secured a £660,000 grant from the Technology Strategy Board, the UK’s innovation agency, towards a £1 million project aimed at accelerating paediatric formulation development through smart design and predictive science.